{"id":158,"date":"2023-05-10T14:13:00","date_gmt":"2023-05-10T14:13:00","guid":{"rendered":"https:\/\/hlrnet.net\/sites\/lvn\/?page_id=158"},"modified":"2023-05-13T16:13:11","modified_gmt":"2023-05-13T16:13:11","slug":"bibliografie","status":"publish","type":"page","link":"https:\/\/hlrnet.net\/sites\/lvn\/bibliografie\/","title":{"rendered":"Bibliografie"},"content":{"rendered":"<ul>\n<li>AbbVie S.A. (2021). <em>Duodopa 20 mg\/ml + 5 mg\/ml, intestinale gel<\/em> [bijsluiter].<\/li>\n<li>Armstrong, R. A. (z.d.). Oculo-Visual Dysfunction in Parkinson\u2019s Disease. Journal of Parkinson\u2019s Disease, 5(4), 715\u2013726. <a href=\"https:\/\/doi.org\/10.3233\/JPD-150686\" class=\"autohyperlink\">doi.org\/10.3233\/JPD-150686<\/a><\/li>\n<li>Aspen Pharma Trading Limited. (2014). <em>KEMADRIN\u2122 5 mg Tabletten<\/em> [bijsluiter].<\/li>\n<li>Azari, A. A., &amp; Barney, N. P. (2013). Conjunctivitis. JAMA\u202f: the journal of the American Medical Association, 310(16), 1721\u20131729. <a href=\"https:\/\/doi.org\/10.1001\/jama.2013.280318\" class=\"autohyperlink\">doi.org\/10.1001\/jama.2013.280318<\/a><\/li>\n<li>Baert, C., &amp; Baert, L. (2021). IBD &amp; Het oog.<\/li>\n<li>BCFI | Antiparkinsonmiddelen. (z.d.). BCFI. Geraadpleegd 6 januari 2023, van <a href=\"https:\/\/www.bcfi.be\/nl\/chapters\/11?frag=8649&#038;view=pvt&#038;vmp_group=28514\" class=\"autohyperlink\">www.bcfi.be\/nl\/chapters\/11?frag=8649&#038;view=pvt&#038;vmp_group=28514<\/a><\/li>\n<li>Buzzi, M., Giannaccare, G., Cennamo, M., Bernabei, F., Rothschild, P.-R., Vagge, A., Scorcia, V., &amp; Mencucci, R. (2022). Ocular Surface Features in Patients with Parkinson Disease on and off Treatment: A Narrative Review. Life (Basel, Switzerland), 12(12), 2141. <a href=\"https:\/\/doi.org\/10.3390\/life12122141\" class=\"autohyperlink\">doi.org\/10.3390\/life12122141<\/a><\/li>\n<li>Chia, S. J., Tan, E.-K., &amp; Chao, Y.-X. (2020). Historical Perspective: Models of Parkinson\u2019s Disease. International Journal of Molecular Sciences, 21(7), E2464. <a href=\"https:\/\/doi.org\/10.3390\/ijms21072464\" class=\"autohyperlink\">doi.org\/10.3390\/ijms21072464<\/a><\/li>\n<li>Choi, J. H., Kim, J. M., Yang, H. K., Lee, H. J., Shin, C. M., Jeong, S. J., Kim, W. S., Han, J. W., Yoon, I. Y., Song, Y. S., &amp; Bae, Y. J. (2020). Clinical Perspectives of Parkinson\u2019s Disease for Ophthalmologists, Otorhinolaryngologists, Cardiologists, Dentists, Gastroenterologists, Urologists, Physiatrists, and Psychiatrists. Journal of Korean Medical Science, 35(28), e230. <a href=\"https:\/\/doi.org\/10.3346\/jkms.2020.35.e230\" class=\"autohyperlink\">doi.org\/10.3346\/jkms.2020.35.e230<\/a><\/li>\n<li>Defazio, G., Hallett, M., Jinnah, H. A., Conte, A., &amp; Berardelli, A. (2017). Blepharospasm 40 years later. Movement Disorders: Official Journal of the Movement Disorder Society, 32(4), 498\u2013509. <a href=\"https:\/\/doi.org\/10.1002\/mds.26934\" class=\"autohyperlink\">doi.org\/10.1002\/mds.26934<\/a><\/li>\n<li>Zien Oogcentrum. (z.d.). <em>Droge ogen<\/em>. Zien Oogcentrum. Geraadpleegd 13 mei 2023, van <a href=\"https:\/\/zien.be\/behandeling\/droge-ogen\/\" class=\"autohyperlink\">zien.be\/behandeling\/droge-ogen\/<\/a><\/li>\n<li>EG. (2022). <em>APO-GO-PEN 10 mg\/ml oplossing voor injectie<\/em> [bijsluiter].<\/li>\n<li>Eyescan. (z.d.). Conjunctivitis. Eyescan. Geraadpleegd 11 mei 2023, van <a href=\"https:\/\/www.eyescan.nl\/oogaandoeningen\/oogontsteking\/ontstoken-slijmvlies-conjunctivitis\/\" class=\"autohyperlink\">www.eyescan.nl\/oogaandoeningen\/oogontsteking\/ontstoken-slijmvlies-conjunctivitis\/<\/a><\/li>\n<li>Galati, Z. (2022, november 1). <em>All Parkinson\u2019s Disease Treatment Options To Help You Manage Your PD<\/em>. Parkinson Foundation. <a href=\"https:\/\/parkinsonfoundation.org\/blog\/parkinsons-disease-treatment?no_redirect=true\" class=\"autohyperlink\">parkinsonfoundation.org\/blog\/parkinsons-disease-treatment?no_redirect=true<\/a><\/li>\n<li>Het Oogziekenhuis Rotterdam. (2023). Oogdruppelhulpmiddelen (informatie voor zorgverleners). Het Oogziekenhuis Rotterdam. <a href=\"https:\/\/www.oogziekenhuis.nl\/oogdruppelhulpmiddelen-informatie-voor-zorgverleners\" class=\"autohyperlink\">www.oogziekenhuis.nl\/oogdruppelhulpmiddelen-informatie-voor-zorgverleners<\/a><\/li>\n<li>Jankovic, J., &amp; Tan, E. K. (2020). Parkinson\u2019s disease: Etiopathogenesis and treatment. Journal of Neurology, Neurosurgery, and Psychiatry, 91(8), 795\u2013808. <a href=\"https:\/\/doi.org\/10.1136\/jnnp-2019-322338\" class=\"autohyperlink\">doi.org\/10.1136\/jnnp-2019-322338<\/a><\/li>\n<li>Laboratorio Farmaceutico S.I.T. (2015). AKINETON 2 mg tabletten [bijsluiter].<\/li>\n<li>Lansa OpticWare. (z.d.). 3MTM Press-OnTM-prisma. Lansa OpticWare. Geraadpleegd 13 mei 2023, van <a href=\"https:\/\/lansaopticware.com\/nl\/product\/prisme-press-on-3m\/\" class=\"autohyperlink\">lansaopticware.com\/nl\/product\/prisme-press-on-3m\/<\/a><\/li>\n<li>LobSor Pharmaceuticals AB. (2022). Lecigimon 20 mg\/ml + 5 mg\/ml + 20 mg\/ml gel voor intestinaal gebruik [bijsluiter].<\/li>\n<li>Mylan EPD. (2020). <em>Parlodel 2,5 mg, tabletten<\/em> [bijsluiter].<\/li>\n<li>Mylan. (2022). <em>Ropinirole Mylan 2 mg filmomhulde tabletten<\/em> [bijsluiter].<\/li>\n<li>N.V. Roche S.A. (2021). <em>Prolopa 250, 200 mg\/50 mg, tabletten<\/em> [bijsluiter].<\/li>\n<li>Orion Corporation. (2022). <em>Eldepryl 5 mg tabletten<\/em> [bijsluiter].<\/li>\n<li>Orion Corporation. (z.d.-a). <em>Comtan 200 mg filmomhulde tabletten<\/em> [bijsluiter].<\/li>\n<li>Orion Corporation. (z.d.-b). <em>Corbilta 50 mg\/12,5 mg\/200 mg filmomhulde tabletten<\/em> [bijsluiter].<\/li>\n<li>Orion Corporation. (z.d.-c) <em>Stalevo 50 mg\/12,5 mg\/200 mg filmomhulde tabletten<\/em> [bijsluiter].<\/li>\n<li>PasseportSant\u00e9. (z.d.). Fond d\u2019oeil: Quand le faire, pourquoi, normal ou pas? PasseportSant\u00e9. Geraadpleegd 13 mei 2023, van <a href=\"https:\/\/www.passeportsante.net\/fr\/Maux\/examens-medicaux-operations\/Fiche.aspx?doc=fond-d-oeil\" class=\"autohyperlink\">www.passeportsante.net\/fr\/Maux\/examens-medicaux-operations\/Fiche.aspx?doc=fond-d-oeil<\/a><\/li>\n<li>Ranu eye specialist. (2013). Bacterial Keratitis. Ranu eye specialist. <a href=\"https:\/\/www.ranueye.com\/bacterial-keratitis-2\/\" class=\"autohyperlink\">www.ranueye.com\/bacterial-keratitis-2\/<\/a><\/li>\n<li>Rota, S., Urso, D., van Wamelen, D. J., Leta, V., Boura, I., Odin, P., Espay, A. J., Jenner, P., &amp; Chaudhuri, K. R. (2022). Why do \u2018OFF\u2019 periods still occur during continuous drug delivery in Parkinson\u2019s disease? Translational Neurodegeneration, 11, 43. <a href=\"https:\/\/doi.org\/10.1186\/s40035-022-00317-x\" class=\"autohyperlink\">doi.org\/10.1186\/s40035-022-00317-x<\/a><\/li>\n<li>Simon, D. K., Tanner, C. M., &amp; Brundin, P. (2020). Parkinson Disease Epidemiology, Pathology, Genetics, and Pathophysiology. Clinics in Geriatric Medicine, 36(1), 1\u201312. <a href=\"https:\/\/doi.org\/10.1016\/j.cger.2019.08.002\" class=\"autohyperlink\">doi.org\/10.1016\/j.cger.2019.08.002<\/a><\/li>\n<li>Sveinbjornsdottir, S. (2016). The clinical symptoms of Parkinson\u2019s disease. Journal of Neurochemistry, 139 Suppl 1, 318\u2013324. <a href=\"https:\/\/doi.org\/10.1111\/jnc.13691\" class=\"autohyperlink\">doi.org\/10.1111\/jnc.13691<\/a><\/li>\n<li>Teofarma S.r.l. (2020). <em>ARTANE 2 mg, tabletten<\/em> [bijsluiter].<\/li>\n<li>Teva B.V. (z.d.). <em>AZILECT 1 mg tabletten<\/em> [bijsluiter].<\/li>\n<li>Tolosa, E., Garrido, A., Scholz, S. W., &amp; Poewe, W. (2021). Challenges in the diagnosis of Parkinson\u2019s disease. The Lancet. Neurology, 20(5), 385\u2013397. <a href=\"https:\/\/doi.org\/10.1016\/S1474-4422(21)00030-2\" class=\"autohyperlink\">doi.org\/10.1016\/S1474-4422(21)00030-2<\/a><\/li>\n<li>Turcano, P., Chen, J. J., Bureau, B. L., &amp; Savica, R. (2019). Early ophthalmologic features of Parkinson\u2019s disease: A review of preceding clinical and diagnostic markers. Journal of Neurology, 266(9), 2103\u20132111. <a href=\"https:\/\/doi.org\/10.1007\/s00415-018-9051-0\" class=\"autohyperlink\">doi.org\/10.1007\/s00415-018-9051-0<\/a><\/li>\n<li>UCB Pharma S.A. (z.d.). <em>Neupro 1 mg\/24 h pleister voor transdermaal gebruik<\/em> [bijsluiter].<\/li>\n<li>Vlaamse Parkinson Liga. (2023). Vlaamse Parkinson Liga. <a href=\"https:\/\/www.parkinsonliga.be\/\" class=\"autohyperlink\">www.parkinsonliga.be\/<\/a><\/li>\n<li>Wu, A., Khawaja, A. P., Pasquale, L. R., &amp; Stein, J. D. (2020). A review of systemic medications that may modulate the risk of glaucoma. Eye (London, England), 34(1), 12\u201328. <a href=\"https:\/\/doi.org\/10.1038\/s41433-019-0603-z\" class=\"autohyperlink\">doi.org\/10.1038\/s41433-019-0603-z<\/a><\/li>\n<li>Zambon S.p.A. (z.d.). <em>Xadago 50 mg filmomhulde tabletten<\/em> [bijsluiter].<\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"<p>AbbVie S.A. (2021). Duodopa 20 mg\/ml + 5 mg\/ml, intestinale gel [bijsluiter]. Armstrong, R. A. (z.d.). Oculo-Visual Dysfunction in Parkinson\u2019s Disease. Journal of Parkinson\u2019s Disease, 5(4), 715\u2013726. <a href=\"http:\/\/doi.org\/10.3233\/JPD-150686\" class=\"autohyperlink\">doi.org\/10.3233\/JPD-150686<\/a> Aspen Pharma Trading Limited. (2014). KEMADRIN\u2122 5 mg Tabletten [bijsluiter]. Azari, A. A., &amp; Barney, N. P. (2013). Conjunctivitis. JAMA\u202f: the journal<\/p>\n","protected":false},"author":7,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-158","page","type-page","status-publish","hentry"],"publishpress_future_action":{"enabled":false,"date":"2026-05-12 10:16:10","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"","extraData":[]},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/hlrnet.net\/sites\/lvn\/wp-json\/wp\/v2\/pages\/158","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/hlrnet.net\/sites\/lvn\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/hlrnet.net\/sites\/lvn\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/hlrnet.net\/sites\/lvn\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/hlrnet.net\/sites\/lvn\/wp-json\/wp\/v2\/comments?post=158"}],"version-history":[{"count":5,"href":"https:\/\/hlrnet.net\/sites\/lvn\/wp-json\/wp\/v2\/pages\/158\/revisions"}],"predecessor-version":[{"id":215,"href":"https:\/\/hlrnet.net\/sites\/lvn\/wp-json\/wp\/v2\/pages\/158\/revisions\/215"}],"wp:attachment":[{"href":"https:\/\/hlrnet.net\/sites\/lvn\/wp-json\/wp\/v2\/media?parent=158"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}